Clinical biomarkers for Lewy body diseases

Clinical biomarkers for Lewy body diseases

Abstract Synucleinopathies are a group of neurodegenerative disorders characterized by pathologic aggregates of neural and glial α-synuclein (α-syn) in the form of Lewy bodies (LBs), Lewy neurites, and cytoplasmic inclusions in both neurons and glia. Two major classes of synucleinopathies are LB dis...

Full description

Bibliographic Details
Main Authors:	Mai M. Abdelmoaty, Eugene Lu, Rana Kadry, Emma G. Foster, Shaurav Bhattarai, R. Lee Mosley, Howard E. Gendelman
Format:	Article
Language:	English
Published:	BMC 2023-11-01
Series:	Cell & Bioscience
Subjects:	Synucleinopathies Parkinson’s disease Parkinson’s disease with dementia Dementia with Lewy bodies α-synuclein Biomarkers
Online Access:	https://doi.org/10.1186/s13578-023-01152-x

Similar Items

Obstructive Sleep Apnea and α-Synucleinopathies: Nationwide Analysis From South Korea’s Healthcare Database
by: Chaeyoung Song, et al.
Published: (2024-06-01)

A rare case of early onset lewy body dementia with parkinsonism associated with chronic exposure to copper contaminated drinking water
by: Marcia H. Ratner, et al.
Published: (2024-09-01)

α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword
by: Li Yang Tan, et al.
Published: (2022-03-01)

Lewy Body Dementias: A Coin with Two Sides?
by: Ángela Milán-Tomás, et al.
Published: (2021-06-01)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
by: David J. Koss, et al.
Published: (2022-07-01)

Plasma Alpha Synuclein as a Potent Biomarker of Diseases with Synucleinopathies
by: Chaisak Dumrikarnlert, et al.
Published: (2023-12-01)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
by: Zachary A. Sorrentino, et al.
Published: (2019-09-01)

Cognitive dysfunction in animal models of human lewy-body dementia
by: Caroline Haikal, et al.
Published: (2024-07-01)

Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings
by: Bethany Peterson, et al.
Published: (2019-03-01)

Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia
by: Chang-ki Oh, et al.
Published: (2022-12-01)

Lewy body diseases and the gut
by: Timothy R. Sampson, et al.
Published: (2025-01-01)

RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies
by: Ilaria Poggiolini, et al.
Published: (2021-05-01)

Leukotriene Signaling as a Target in α-Synucleinopathies
by: Katharina Strempfl, et al.
Published: (2022-02-01)

Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
by: Michiyo Iba, et al.
Published: (2024-04-01)

Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline
by: Anna Emdina, et al.
Published: (2022-05-01)

Clinicopathological Correlates of Lewy Body Disease: Fundamental Issues
by: Tae-Beom Ahn
Published: (2010-05-01)

Quantitative proteomic analysis using a mouse model of Lewy body dementia induced by α-synuclein preformed fibrils injection
by: Fatih Akkentli, et al.
Published: (2024-10-01)

Dementia with Lewy bodies
by: O. S. Levin, et al.
Published: (2018-11-01)

Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies
by: Tu, Haitao, et al.
Published: (2022)

Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein
by: Samuel T. Peters, et al.
Published: (2020-06-01)

Carboxyl truncation of α-synuclein occurs early and is influenced by human APOE genotype in transgenic mouse models of α-synuclein pathogenesis
by: Grace M. Lloyd, et al.
Published: (2023-07-01)

Sex differences in alpha-synucleinopathies: a systematic review
by: Kausar Raheel, et al.
Published: (2023-07-01)

A 14-day pulse of PLX5622 modifies α-synucleinopathy in preformed fibril-infused aged mice of both sexes
by: Tarun N. Bhatia, et al.
Published: (2023-08-01)

Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer’s disease
by: Lauren Walker, et al.
Published: (2024-02-01)

Novel approaches targeting α-Synuclein for Parkinson's Disease: Current progress and future directions for the disease-modifying therapies
by: David Baggett, et al.
Published: (2024-12-01)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
by: Kensuke Ikenaka, et al.
Published: (2019-07-01)

The thinking on controversy of "1-year rule" for differential diagnosis between Parkinson's disease dementia and dementia with Lewy bodies
by: Shu-hua LI, et al.
Published: (2017-01-01)

The Role of EEG in the Diagnosis, Prognosis and Clinical Correlations of Dementia with Lewy Bodies—A Systematic Review
by: Zhe Kang Law, et al.
Published: (2020-08-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

Cognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change
by: Jon B. Toledo, et al.
Published: (2024-12-01)

α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
by: Hung-Hsiang Ho, et al.
Published: (2024-11-01)

Peripheral blood inflammatory cytokines in prodromal and overt α-synucleinopathies: a review of current evidence
by: Jin-Sun Jun, et al.
Published: (2023-07-01)

The Pharmacology of Visual Hallucinations in Synucleinopathies
by: Mirella Russo, et al.
Published: (2019-12-01)

Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer’s disease but not Lewy body dementias
by: Yuek Ling Chai, et al.
Published: (2023-05-01)

β-Synuclein: An Enigmatic Protein with Diverse Functionality
by: Junna Hayashi, et al.
Published: (2022-01-01)

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
by: Arnab Datta, et al.
Published: (2017-08-01)

A novel function for α-synuclein as a regulator of NCK2 in olfactory bulb: implications for its role in olfaction
by: Jing Ren, et al.
Published: (2024-11-01)

Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)

Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells
by: Cathryn L. Ugalde, et al.
Published: (2020-01-01)